M
MRVI
Maravai Lifesciences Holdings, I…
4.150
-0.140-3.26%Pre Market: 4.160 +0.010 +0.24%05:06 05/18 EDT
OPEN/PREV CLOSE4.210/4.290
TODAY RANGE4.100-4.225
VOL24
MARKET CAP1.07B
52 WEEK RANGE1.950-4.995
AVG VOL (3M)1.99M
% TURNOVER0.60%
TURNOVER--
P/E (TTM)-5.7439
% RANGE2.91%
EPS(TTM)-0.7225
P/E(FORWARD)-16.2745
P/B5.06
BVPS0.8194
DIVIDEND--
P/S5.72
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP455.85M
SHARES OUTSTANDING258.19M
NEXT EARNINGS08/10-08/14
FREE FLOAT109.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
Maravai LifeSciences Q1 Turnaround Spurs Rethink Of CleanCap Driven Outlook
TipRanks·6d ago
Maravai Lifesciences Signals Turnaround in Earnings Call
The Motley Fool·05/09 20:35
Maravai (MRVI) Q1 2026 Earnings Transcript
Simply Wall St·05/09 02:35
Maravai LifeSciences Holdings (MRVI) EPS Loss Deepens Narrative On Persistent Profitability Concerns
Benzinga·05/08 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·05/08 16:06
Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
Dow Jones·05/08 13:44
Maravai LifeSciences Is Maintained at Overweight by Wells Fargo
Dow Jones·05/08 13:44
Maravai LifeSciences Price Target Raised to $5.50/Share From $4.50 by Wells Fargo
TipRanks·05/08 11:26
William Blair Sticks to Its Hold Rating for Maravai Lifesciences Holdings (MRVI)
Seeking Alpha·05/07 21:39
Maravai LifeSciences Holdings GAAP EPS of -$0.02 beats by $0.07, revenue of $65.8M beats by $12.8M
TipRanks·05/07 21:08
Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.